Get started
Author

Zena N. Willsmore

Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
2021 · Zena N. Willsmore, Ben G. T. Coumbe, et al. · European Journal of Immunology · 222
PDF
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
2021 · Zena N. Willsmore, Robert J. Harris, et al. · Frontiers in Immunology · 81
PDF
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade
2022 · Akshay J. Patel, Zena N. Willsmore, et al. · Nature Communications · 77
PDF
Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series
2019 · Z.N. Willsmore, R.T. Woolf, et al. · British Journal of Dermatology · 74
Enriched circulating and tumor-resident TGF-β + regulatory B cells in patients with melanoma promote FOXP3 + Tregs
2022 · Robert J Harris, Zena Willsmore, et al. · OncoImmunology · 51
PDF
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
2023 · Silvia Crescioli, Isabel Correa, et al. · Nature Communications · 44
PDF
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma
2024 · Shabana Habib, Gabriel Osborn, et al. · Expert Review of Clinical Immunology · 32
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
2022 · Rebecca Adams, Gabriel Osborn, et al. · OncoImmunology · 29
PDF
Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response
2021 · Alistair Robson, Farrah Bakr, et al. · American Journal of Dermatopathology · 17
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma
2025 · Zena N Willsmore, Lucy Booth, et al. · Journal for ImmunoTherapy of Cancer · 15
Non‐Allergic Urticarial Skin Reactions Associated With MOv18 IgE , a First‐In‐Class IgE Antibody Recognising Folate Receptor Alpha
2025 · Chara Stavraka, Jitesh Chauhan, et al. · Allergy · 7
Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response.
2021 · Alistair Robson, Farrah Bakr, et al. · PubMed · 3
Sat0376 Does Suppression of Il-4 and Il-13 Lead to the Development of New Onset Spondylo-arthritis in Susceptible Patients?
2020 · C. Hughes, B. Menon, et al. · Annals of the Rheumatic Diseases · 2
PDF
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy
2026 · Lucy Booth, Rebecca Adams, et al. · Journal for ImmunoTherapy of Cancer · 1
A Problem of Classification: 2 Cases of Epstein–Barr Virus + Primary Cutaneous Plasmacytoma Arising in Immunocompetent Elderly Patients
2021 · Alistair Robson, Werner Kempf, et al. · American Journal of Dermatopathology · 1
Merkel cell carcinoma: Lessons from a review of 15 year outcomes of the multidisciplinary management at a UK tertiary referral centre
2026 · Anna Y Allan, Khushboo Sinha, et al. · JPRAS Open
PDF
FP11 Circulating immunoregulatory B- and T-cell profiles in patients with melanoma modulated with checkpoint inhibitor immunotherapy
2026 · Lucy Booth, Zena Willsmore, et al. · British Journal of Dermatology
P076 A multicentre evaluation of surveillance outcomes and phenotypic trends in carriers of CDKN2A pathogenic variants
2026 · Isabelle Nicholls, Peter Robinson, et al. · British Journal of Dermatology
O19 Nonallergic urticarial skin reactions associated with MOv18 IgE, a first-in-class IgE antibody recognizing folate receptor alpha (FRα): linking allergooncology with dermatology
2026 · Jitesh Chauhan, Chara Stavraka, et al. · British Journal of Dermatology
O20 Advanced melanoma is associated with distinct circulating B-cell profiles enriched with immunoregulatory and autoreactive features
2023 · Zena Willsmore, Silvia Crescioli, et al. · British Journal of Dermatology
The Histopathology of Melanocytic Nevi and Malignant Melanoma
2021 · Zena Willsmore, Alistair Robson · Springer eBooks
P266 IL-4/13 inhibitor dupilumab associated with new onset peripheral axial spondyloarthritis in patients with atopic dermatitis
2020 · Catherine D Hughes, Bina Menon, et al. · Rheumatology
PDF
Works count: 22
Citation count: 656
H-index: 10
I10-index: 10
Year
Topic
Type